SEPN
Price:
$35.95
Market Cap:
$1.62B
Septerna, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to the identification and advancement of orally administered, small molecule therapies that modulate G protein-coupled receptors (GPCRs). The company's pipeline is designed to address a spectrum of conditions within endocrinology, immunology and inflammation, and metabolic disorders. Among its key programs, Septerna is developing SEP-786, an oral small molecule serving as a PTH1R agonist for individuals suffering from hypoparathyroidism. Another candidate, SEP-631, is an oral small molecule MRGPRX2 NAM aimed at treating chronic spontaneous urticaria and other mast cell-related ailments. Furthermore, its T...[Read more]
Industry
Biotechnology
IPO Date
2024-10-25
Stock Exchange
NASDAQ
Ticker
SEPN
According to Septerna, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -44.94. This represents a change of 360.39% compared to the average of -9.76 of the last 4 quarters.
The mean historical PE Ratio of Septerna, Inc. over the last ten years is 15.68. The current -44.94 PE Ratio has changed -28768.18% with respect to the historical average. Over the past ten years (40 quarters), SEPN's PE Ratio was at its highest in in the September 2025 quarter at 25.51. The PE Ratio was at its lowest in in the March 2026 quarter at -31.13.
Average
15.68
Median
-5.93
Minimum
-25.24
Maximum
99.81
Discovering the peaks and valleys of Septerna, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual PE Ratio = 99.81
Minimum Annual Increase = -111.89%
Minimum Annual PE Ratio = -25.24
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -25.24 | 112.80% |
| 2024 | -11.86 | -111.89% |
| 2023 | 99.81 | Infinity% |
The current PE Ratio of Septerna, Inc. (SEPN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
20.90
5-year avg
15.68
10-year avg
15.68
Septerna, Inc.’s PE Ratio is less than Bicara Therapeutics Inc. Common Stock (-8.37), less than Tango Therapeutics, Inc. (-41.43), less than Fortrea Holdings Inc. (-3.36), less than Prime Medicine, Inc. (-2.48), less than Kura Oncology, Inc. (-2.72), less than EyePoint Pharmaceuticals, Inc. (-4.13), less than ProKidney Corp. (-3.11), less than Maravai LifeSciences Holdings, Inc. (-6.97), less than Nurix Therapeutics, Inc. (-6.32), less than Arbutus Biopharma Corporation (5.14),
| Company | PE Ratio | Market cap |
|---|---|---|
| -8.37 | $1.19B | |
| -41.43 | $3.85B | |
| -3.36 | $1.56B | |
| -2.48 | $501.21M | |
| -2.72 | $803.41M | |
| -4.13 | $1.09B | |
| -3.11 | $551.46M | |
| -6.97 | $1.38B | |
| -6.32 | $1.47B | |
| 5.14 | $841.51M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Septerna, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Septerna, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Septerna, Inc.'s PE Ratio?
How is the PE Ratio calculated for Septerna, Inc. (SEPN)?
What is the highest PE Ratio for Septerna, Inc. (SEPN)?
What is the 3-year average PE Ratio for Septerna, Inc. (SEPN)?
What is the 5-year average PE Ratio for Septerna, Inc. (SEPN)?
How does the current PE Ratio for Septerna, Inc. (SEPN) compare to its historical average?